A Study to Evaluate the Impact of Adalimumab on Quality of Life, Health Care Utilization and Costs of Ulcerative Colitis Subjects in the Usual Clinical Practice Setting
Clinical trial NCT01550965 · COMPLETED
Trial details
- NCT number
- NCT01550965
- Sponsor
- AbbVie (prior sponsor, Abbott)
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-01
- Primary completion
- 2015-04-01
- Enrollment
- 463
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.